Cellular and Molecular Immunology,
Journal Year:
2023,
Volume and Issue:
21(2), P. 134 - 143
Published: Dec. 25, 2023
Abstract
Numerous
pathogens
can
infect
the
olfactory
tract,
yet
pandemic
caused
by
SARS-CoV-2
has
strongly
emphasized
importance
of
mucosa
as
an
immune
barrier.
Situated
in
nasal
passages,
is
directly
exposed
to
environment
sense
airborne
odorants;
however,
this
also
means
it
serve
a
direct
route
entry
from
outside
world
into
brain.
As
result,
olfactotropic
infections
have
serious
consequences,
including
dysfunction
system,
CNS
invasion,
dissemination
lower
respiratory
and
transmission
between
individuals.
Recent
research
shown
that
distinctive
response
needed
protect
neuronal
mucosal
tissue.
A
better
understanding
innate,
adaptive,
structural
barriers
develop
effective
therapeutics
vaccines
against
microbes
such
SARS-CoV-2.
Here,
we
summarize
ramifications
infection
mucosa,
review
subsequent
response,
discuss
important
areas
future
for
immunity
infectious
disease.
Cellular and Molecular Immunology,
Journal Year:
2024,
Volume and Issue:
21(9), P. 943 - 958
Published: July 12, 2024
Abstract
Many
newly
emerging
and
re-emerging
viruses
have
neuroinvasive
potential,
underscoring
viral
encephalitis
as
a
global
research
priority.
Upon
entry
of
the
virus
into
CNS,
severe
neurological
life-threatening
conditions
may
manifest
that
are
associated
with
high
morbidity
mortality.
The
currently
available
therapeutic
arsenal
against
is
rather
limited,
emphasizing
need
to
better
understand
local
antiviral
immunity
within
infected
CNS.
In
this
review,
we
discuss
new
insights
pathophysiology
encephalitis,
focus
on
myeloid
cells
CD8
+
T
cells,
which
critically
contribute
protection
CNS
infection.
By
illuminating
prerequisites
cell
activation,
discussing
discoveries
regarding
their
transcriptional
signatures,
dissecting
mechanisms
recruitment
sites
replication
aim
further
delineate
complexity
responses
Moreover,
summarize
current
knowledge
in
field
infection
neurodegeneration
potential
links
some
neurotropic
certain
pathological
hallmarks
observed
neurodegeneration.
Frontiers in Cellular Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: Sept. 16, 2022
SARS-CoV-2
causes
COVID-19,
which
has
claimed
millions
of
lives.
This
virus
can
infect
various
cells
and
tissues,
including
the
brain,
for
numerous
neurological
symptoms
have
been
reported,
ranging
from
mild
non-life-threatening
(e.g.,
headaches,
anosmia,
dysgeusia,
disorientation)
to
severe
life-threatening
meningitis,
ischemic
stroke,
cerebral
thrombosis).
The
cellular
receptor
is
angiotensin-converting
enzyme
2
(ACE2),
an
that
belongs
renin-angiotensin
system
(RAS).
RAS
endocrine
classically
associated
with
regulating
blood
pressure
fluid
electrolyte
balance;
however,
it
also
involved
in
promoting
inflammation,
proliferation,
fibrogenesis,
lipogenesis.
Two
pathways
constitute
counter-balancing
effects,
key
its
regulation.
first
axis
(classical)
composed
(ACE),
angiotensin
(Ang)
II,
type
1
(AT1R)
as
main
effector,
-when
activated-
increases
production
aldosterone
antidiuretic
hormone,
sympathetic
nervous
tone,
pressure,
vasoconstriction,
fibrosis,
reactive
oxygen
species
(ROS)
production.
Both
systemic
local
classical
RAS’
within
brain
are
cognitive
impairment,
cell
death,
inflammation.
second
(non-classical
or
alternative)
includes
ACE2,
converts
Ang
II
Ang-(1–7),
a
peptide
molecule
activates
Mas
(MasR)
charge
opposing
II/AT1R
actions.
Thus,
alternative
enhances
cognition,
synaptic
remodeling,
survival,
signal
transmission,
antioxidant/anti-inflammatory
mechanisms
brain.
In
physiological
state,
both
axes
remain
balanced.
However,
some
factors
dysregulate
arms.
binding
ACE2
internalization
degradation
this
enzyme,
reducing
activity,
disrupting
balance
RAS,
partially
explain
appearance
COVID-19.
Therefore,
review
aims
analyze
role
development
effects
due
infection.
Moreover,
we
will
discuss
RAS-molecular
targets
could
be
used
therapeutic
purposes
treat
short
long-term
COVID-19-related
sequelae.
Cellular and Molecular Immunology,
Journal Year:
2023,
Volume and Issue:
21(2), P. 134 - 143
Published: Dec. 25, 2023
Abstract
Numerous
pathogens
can
infect
the
olfactory
tract,
yet
pandemic
caused
by
SARS-CoV-2
has
strongly
emphasized
importance
of
mucosa
as
an
immune
barrier.
Situated
in
nasal
passages,
is
directly
exposed
to
environment
sense
airborne
odorants;
however,
this
also
means
it
serve
a
direct
route
entry
from
outside
world
into
brain.
As
result,
olfactotropic
infections
have
serious
consequences,
including
dysfunction
system,
CNS
invasion,
dissemination
lower
respiratory
and
transmission
between
individuals.
Recent
research
shown
that
distinctive
response
needed
protect
neuronal
mucosal
tissue.
A
better
understanding
innate,
adaptive,
structural
barriers
develop
effective
therapeutics
vaccines
against
microbes
such
SARS-CoV-2.
Here,
we
summarize
ramifications
infection
mucosa,
review
subsequent
response,
discuss
important
areas
future
for
immunity
infectious
disease.